1.
Parker SL,
Tong T,
Bolden S et al (1996) Cancer statistics 1996.
CA Cancer J Clin 46:5–27
2.
Curado MP,
Hashibe M.
Recent changes in the epidemiology of head and neck cancer.
Curr Opin Oncol.
2009;21:194–200.
doi:10.1097/CCO.0b013e32832a68ca.
3.
Goerres GW,
Mosna-Firlejczyk K,
Steurer J,
von Schulthess GK,
Bachmann LM (2003) Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis.
Eur J Nucl Med Mol Imaging 30:562–571
4.
Bruschini P,
Giorgetti A,
Bruschini L,
Nacci A,
Volterrani D,
Cosottini M,
Ursino F,
Mariani G,
Fattori B (2003) Positron emission tomography (PET) in the staging of the head neck cancer: comparison between PET and CT.
Acta Otorhinolaryngol Ital 23:446–453
5.
Huang SH1,
Chien CY,
Lin WC,
Fang FM,
Wang PW,
Lui CC,
Huang YC,
Hung BT,
Tu MC,
Chang CC.
A comparative study of fused FDG PET/MRI,
PET/CT,
MRI,
and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma.
Clin Nucl Med.
2011 Jul;36(7):518-25.
doi: 10.1097/RLU.0b013e318217566f.
6.
van den Brekel MW,
Stel HV,
Castelijns JA,
et al.
Cervical lymph node metastasis: assessment of radiologic criteria.
Radiology.
1990;177:379–84.
7.
Steinkamp HJ,
Cornehl M,
Hosten N,
Pegios W,
Vogl T,
Felix R.
Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy.
Br J Radiol.
1995;68:266–70.
8.
King AD,
Tse GM,
Ahuja AT,
et al.
Necrosis in metastatic neck nodes: diagnostic accuracy of CT,
MR imaging,
and US.
Radiology.
2004;230:720–6.
doi:10.1148/radiol.2303030157.
9.
de Bondt RB,
Nelemans PJ,
Bakers F,
et al.
Morphological MRI criteria improve the detection of lymph node metastases in head and neck squamous cell carcinoma: multivariate logistic regression analysis of MRI features of cervical lymph nodes.
Eur Radiol.
2009;19:626–33.
doi:10.1007/s00330-008-1187-3.
10.
Stuckensen T,
Kovacs AF,
Adams S,
Baum RP.
Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET,
ultrasound,
CT and MRI.
J Craniomaxillofac Surg.
2000;28:319–24.
doi:10.1054/jcms.2000.0172
11.
Konstantin Holzapfel a,∗,
Sabrina Duetschb,
Claudius Fauserb,
Matthias Eibera,
Ernst J.
Rummenya,
Jochen Gaaa.
Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.
European Journal of Radiology 72 (2009) 381–387
12.
Stokkel MP,
ten Broek FW,
Hordijk GJ,
Koole R,
van Rijk PP.
Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Ann Surg 000;231(2):229–34.
13.
Ng SH,
Yen TC,
Liao CT,
Chang JT,
Chan SC,
Ko SF,
et al.
18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
J Nucl Med 2005;46(7):1136–43.
14.
Ng SH,
Yen TC,
Chang JT,
Chan SC,
Ko SF,
Wang HM,
et al.
Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
J Clin Oncol 2006;24(27):4371–6.
15.
Roh JL,
Yeo NK,
Kim JS,
Lee JH,
Cho KJ,
Choi SH,
et al.
Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Oral Oncol 2007;43(9):887–93.
16.
Murakami R,
Uozumi H,
Hirai T,
Nishimura R,
Shiraishi S,
Ota K,
et al.
Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Int J Radiat Oncol Biol Phys 2007;68(2):377–82.
17.
Yamazaki Y,
Saitoh M,
Notani K,
Tei K,
Totsuka Y,
Takinami S,
et al.
Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
Ann Nucl Med 2008;22(3):177–84.
18.
Rodrigues RS,
Bozza FA,
Christian PE,
Hoffman JM,
Butterfield RI,
Christensen CR,
et al.
Comparison of whole-body PET/CT,
dedicated high-resolution head and neck PET/CT,
and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
J Nucl Med 2009;50(8):1205–13.
19.
Scott AM,
Gunawardana DH,
Bartholomeusz D,
Ramshaw JE,
Lin P.
PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study.
J Nucl Med 2008;49(10):1593–600.
20.
Lonneux M,
Hamoir M,
Reychler H,
Maingon P,
Duvillard C,
Calais G,
et al.
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
J Clin Oncol 2010;28(7):1190–5.
21.
Samant S,
Robbins KT.
Evolution of neck dissection for improved functional outcome.
World J Surg 2003;27(7):805–10.
22.
Ferlito A,
Rinaldo A,
Silver CE,
Shah JP,
Suárez C,
Medina JE,
et al.
Neck dissection: then and now.
Auris Nasus Larynx 2006;33(4):365–74.
23.
Madison MT,
Remley KB,
Latchaw RE,
Mitchell SL (1994) Radiologic diagnosis and staging of head and neck squamous cell carcinoma.
Radiol Clin North Am 32:163–181
24.
Rege S,
Maass A,
Chaiken L et al (1994) Use of positron emission tomograpy with fluorodeoxyglucose in patients with extracranial head and neck cancers.
Cancer 73:3047–3058
25.
Comoretto M,
Balestreri L,
Borsatti E,
Cimitan M,
Franchin G,
Lise M (2008) Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.
Radiology 249:203–11
26.
Braams JW,
Pruim J,
Freling NJ et al (1995) Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI.
J Nucl Med 36:211–216
27.
Kau RJ,
Alexiou C,
Laubenbacher C,
Werner M,
Schwaiger M,
Arnold W (1999) Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F18 in a routine clinical setting.
Arch Otolaryngol Head Neck Surg 125:1322–1328
28.
Laubenbacher C,
Saumweber D,
Wagner-Manslau C et al (1995) Comparison of fluorine-18-fluorodeoxyglucose PET,
MRI and endoscopy for staging head and neck squamous-cell carcinomas.
J Nucl Med 36:1747–1757
29.
Haberkorn U,
Strauss LG,
Reisser C et al (1991) Glucose uptake,
perfusion and cell proliferation in head and neck
tumors: relation of positron emission tomography to flow cytometry.
J Nucl Med 32:1548–1555
30.
Jabour BA,
Choi Y,
Hoh CK et al (1993) Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-glucose and MR imaging correlation.
Radiology 186:27–35
31.
Loeffelbein DJ,
Souvatzoglou M,
Wankerl V,
Martinez-Möller A,
Dinges J,
Schwaiger M,
Beer AJ.
PET-MRI.
Fusion in Head-and-Neck Oncology: Current Status and Implications for Hybrid PET/MRI.
J Oral Maxillofac Surg.
2012 Feb;70(2):473-83.
Epub 2011 May 20.
32.
Kim SY,
Kim JS,
Doo H,
Lee H,
Lee JH,
Cho KJ,
Choi SH,
Nam SY,
Roh JL.
Combined 18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
Oral Oncol.
2011 May;47(5):376-80.
Epub 2011 Apr 5
33.
Kim SY,
Kim JS,
Yi JS,
Lee JH,
Choi SH,
Nam SY,
Cho KJ,
Lee SW,
Kim SB,
Roh JL.
Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Ann Surg Oncol.
2011 Sep;18(9):2579-84.
Epub 2011 Mar 16
34.
Boss A,
Stegger L,
Bisdas S,
Kolb A,
Schwenzer N,
Pfister M,
Claussen CD,
Pichler BJ,
Pfannenberg C.
Feasibility of simultaneous PET/MR imaging in the head and upper neck area.
Eur Radiol.
2011 Jul;21(7):1439-46.
Epub 2011 Feb 10
35 Huang S-H,
Chien C-Y,
Lin W-C,
Fang F-M,
Wang P-W,
Lui C-C,
et al.
A comparative study of fused FDG PET/MRI,
PET/CT,
MRI,
and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma.
Clin Nucl Med 2011; 36: 518–25.
doi: 10.1097/ RLU.0b013e318217566f
36 Kanda T,
Kitajima K,
Suenaga Y,
Konishi J,
Sasaki R,
Morimoto K,
et al.
Value of retrospective image fusion of F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
Eur J Radiol 2013; 82: 2005–10.
doi: 10.1016/j.
ejrad.2013.06.025